Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: European Commission Grants SOBI Marketing Authorisation For Altuvoct For Treatment Of Haemophilia A

June 19 (Reuters) - Swedish Orphan Biovitrum AB (publ)
 SOBIV.ST :
    * EUROPEAN COMMISSION GRANTS SOBI MARKETING AUTHORISATION
FOR
ALTUVOCT FOR TREATMENT OF HAEMOPHILIA A

Source text for Eikon:  ID:nPnbqb3K2a 
Further company coverage:  SOBIV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news